Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK Not Planning To Add to Regulatory Burden for Life Science Industry Post-Brexit

Executive Summary

The UK seemingly has no intention of imposing new regulatory requirements on life science companies after the country leaves the EU. That’s all well and good, but companies in the UK looking to continue doing business in the EU are worried they will face significant trade barriers post-Brexit. Everything will depend on the outcome of soon-to-start exit negotiations.


Related Content

Regulatory Alignment Of UK With EU Post-Brexit Seen As Critical
EU National Agencies Prepare For ‘Rebalancing’ Of Network Post Brexit
UK ‘Needs To Be On EU’s API White List’ Post-Brexit





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts